Naturally occurring parainfluenza virus 3 infection in adults induces mild exacerbation of asthma associated with increased sputum concentrations of cysteinyl leukotrienes

International Archives of Allergy and Immunology

Volumn 138, Issue 3, 2005, Pages 267-272

  Matsuse, Hiroto ^a   Kondo, Yuki ^a   Saeki, Sachiko ^a   Nakata, Hiroko ^a   Fukushima, Chizu ^a   Mizuta, Yohei ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Asthma; Cysteinyl leukotrienes; Induced sputum; Parainfluenza virus 3

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 5; MARKER; PEPTIDOLEUKOTRIENE; VIRUS RNA;

ADULT; ARTICLE; ASPIRATION; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HUMAN; LEUKOCYTE DIFFERENTIAL COUNT; MALE; NASOPHARYNX; PARAINFLUENZA VIRUS 3; PEAK EXPIRATORY FLOW; PREDICTION; PRIORITY JOURNAL; SPUTUM ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS INFECTION;

ADULT; ASTHMA; CYTOKINES; EOSINOPHIL CATIONIC PROTEIN; FEMALE; HUMANS; LEUKOCYTES; LEUKOTRIENE D4; MALE; MIDDLE AGED; PARAINFLUENZA VIRUS 3, HUMAN; RECURRENCE; RESPIROVIRUS INFECTIONS; SPUTUM;

EID: 27544507363     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088728     Document Type: Article

References (40)

1. Busse WW, Lemanske RF: Asthma (review). N Engl J Med 2001;344:350-362.
2. Dahlen SE, Hedqvist P, Hammarstrom S, et al: Leukotrienes are potent constrictors of human bronchi. Nature 1980;288:484-486.
3. Drasen JM, Austen KF: Leukotrienes and airway responses. Am Rev Respir Dis 1987;136:368-372.
4. Laitinen LA, Laitinen A, Haahtela T, et al: Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet 1993;341:989-990.
5. Kawano T, Matsuse H, Kondo Y, et al: Cysteinyl leukotrienes induce nuclear factor κB activation and RANTES production in a murine model of asthma. J Allergy Clin Immunol 2003;112:369-374.
6. National Heart, Lung and Blood Institute: Global Strategy for Asthma Management and Prevention. Bethesda, National Institutes of Health, 2002.
7. Johnston SL: Viruses and asthma. Allergy 1998;53:922-932.
8. Gern JE: Viral and bacterial infections in the development and progression of asthma. J Allergy Clin Immunol 2000;105:S497-S502.
9. Matsuse H, Behera AK, Kumar M, et al: Differential cytokine mRNA expression in Dermatophagoides farinae allergen-sensitized and respiratory syncytial virus-infected mice. Microbes Infect 2000;2:753-760.
10. Matsuse H, Behera AK, Kumar M, et al: Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness. J Immunol 2000;164:6583-6592.
11. Kondo Y, Matsuse H, Machida I, et al: Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma. Clin Exp Allergy 2004;34:1307-1313.
12. Kondo Y, Matsuse H, Machida I, et al: Regulation of mite allergen-pulsed murine dendritic cells by respiratory syncytial virus. Am J Respir Crit Care Med 2004;169:494-498.
13. van Schaik SM, Tristram DA, Nagpal IS, et al: Increased production of IFN-γ and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol 1999;103:630-636.
14. Sznajer Y, Westcott JY, Wenzel SE, et al: Airway eicosanoids in acute severe respiratory syncytial virus bronchiolitis. J Pediatr 2004;145:115-118.
15. Dimova-Yaneva D, Russell D, Main M, et al: Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis. Clin Exp Allergy 2004;34:555-558.
16. Grunberg K, Smits HH, Timmers MC, et al: Experimental rhinovirus 16 infection. Effects on cell differentiation and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med 1997;156:609-616.
17. Grunberg K, Sharon RF, Sont JK, et al: Rhinovirus-induced airway inflammation in asthma. Effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med 2001;164:1816-1822.
18. Seymour ML, Gilby N, Bardin PG, et al: Rhinovirus infection increases 5-lipoxygenase and cycloxygenase-2 in bronchial biopsy specimens from nonatopic subjects. J Infect Dis 2002;185:540-544.
19. Gentile DA, Fireman P, Skoner DP: Elevations of local leukotriene C4 levels during viral upper respiratory tract infections. Ann Allergy Asthma Immunol 2003;91:270-274.
20. Mckean MC, Hewitt C, Lambert PC, et al: An adult model of exclusive viral wheeze: inflammation in the upper and lower respiratory tracts. Clin Exp Allergy 2003;33:912-920.
21. Borg I, Rohde G, Loseke S, et al: Evaluation of a quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary disease. Eur Respir J 2003;21:944-951.
22. Collins CL, Pollard AJ: Respiratory syncytial virus infections in children and adults. J Infect 2002;45:10-17.
23. Hall CB: Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917-1928.
24. Nicholson KG, Kent J, Ireland DC: Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:982-986.
25. Osiowy C: Direct detection of respiratory syncytial virus, parainfluenza virus, and adenovirus in clinical respiratory specimens by a multiplex reverse transcription-PCR assay. J Clin Microbiol 1998;36:3149-3154.
26. Rohde G, Wiethege A, Borg I, et al: Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalization: a case-control study. Thorax 2003;58:37-42.
27. 4 and inhibits aspirin-induced asthma to threshold dose of aspirin. J Allergy Clin Immunol 2004;114:1278-1281.
28. Krishnan S, Craven M, Welliver RC: Differences in participation of innate and adaptive immunity to respiratory syncytial virus in adults and neonates. J Infect Dis 2003;188:433-439.
29. Behera AK, Kumar M, Matsuse H, et al: Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells. Biochem Biophys Res Commun 1998;251:704-709.
30. Wedde-Beer K, Hu C, Rodriguez MM, et al: Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus. Am J Physiol Lung Cell Mol Physiol 2002;282:L1143-L1150.
31. Doull IJ, Lampe FC, Smith S, et al: Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial. BMJ 1997;315:858-862.
32. Svedmyr J, Nyberg E, Asbrink-Nilsson E, et al: Intermittent treatment with inhaled steroids for deterioration of asthma due to upper respiratory tract infections. Acta Paediatr 1995;84:884-888.
33. Garrett J, Williams S, Wong C, et al: Treatment of acute asthmatic exacerbations with increased dose of inhaled steroid. Arch Dis Child 1998;79:12-17.
34. Schuh S, Reisman J, Alshehri M, et al: A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med 2000;343:689-694.
35. Oehling AG, Akdis CA, Schapowal A, et al: Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma. Allergy 1997;52:144-154.
36. Gustafson LM, Proud D, Hendley JO, et al: Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 1996;97:1009-1014.
37. Dworski R, Fitzgerald GA, Oates JA, et al: Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994;149:953-959.
38. Bisgaard H, Zielen S, Garcia-Garcia ML, et al: Montelukast reduces asthma exacerbation in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 2005;171;315-322.
39. Williams JV, Harris PA, Tollefson SJ, et al: Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 2004;350:443-450.
40. Bitko V, Musiyenko A, Shulyayeva O, et al: Inhibition of respiratory viruses by nasally administered siRNA. Nat Med 2005;11:50-55.